Dr. Rajni Agarwal, MD
Claim this profileLucile Packard Children's Hospital
Area of expertise
Fanconi Anemia
Rajni Agarwal, MD has run 2 trials for Fanconi Anemia. Some of their research focus areas include:
Panmyelopathy
Rajni Agarwal, MD has run 1 trial for Panmyelopathy. Some of their research focus areas include:
Affiliated Hospitals
Lucile Packard Children's Hospital
Stanford University
Clinical Trials Rajni Agarwal, MD is currently running
Stem Cell Transplant with T-allo10 Addback
for Blood Diseases
The purpose of this study is to determine the safety of a cell therapy, T-allo10, after αβdepleted-HSCT in the hopes that it will boost the adaptive immune reconstitution of the patient while sparing the risk of developing severe Graft-versus-Host Disease (GvHD). The primary objective of Phase 1a is to determine the recommended Phase 2 dose (RP2D) administered after infusion of αβdepleted-HSCT in children and young adults with hematologic malignancies. A Phase 1b extension will occur after dose escalation, enrolling at the RP2D for the T-allo10 cells determined in the Phase 1 portion to evaluate the safety and efficacy of infusion of T-allo10 after receipt of αβdepleted-HSCT. Additionally, Phase 1b aims to explore improvements in immune reconstitution. All participants on this study must be enrolled on another study: NCT04249830
Recruiting
1 award
Phase 1
6 criteria
Stem Cell Transplant + JSP191
for Fanconi Anemia
The objective of this clinical trial is to develop a cell therapy for Fanconi Anemia which enables enhanced donor hematopoietic and immune reconstitution with decreased toxicity by transplanting depleted stem cells from a donor with and without using an experimental antibody treatment called JSP-191 as a part of conditioning. This experimental treatment will hopefully cause fewer side effects than chemotherapy (the current standard of care method). Participants will be administered the conditioning regimen, are assessed until they receive the depleted stem cell infusion, and will be followed for up to 2 years after the cell infusion.
Recruiting
1 award
Phase 1 & 2
5 criteria
More about Rajni Agarwal, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Rajni Agarwal, MD has experience with
- Depleted Stem Cell Transplant
- JSP191
- RP-L102
- Allogeneic Stem Cell Transplant
- CliniMACS Prodigy System
- T-allo10 Cells Addback
Breakdown of trials Rajni Agarwal, MD has run
Panmyelopathy
Fanconi Syndrome
Bone Marrow Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajni Agarwal, MD specialize in?
Rajni Agarwal, MD focuses on Fanconi Anemia and Panmyelopathy. In particular, much of their work with Fanconi Anemia has involved FANCA positive patients, or patients who are FANCC positive.
Is Rajni Agarwal, MD currently recruiting for clinical trials?
Yes, Rajni Agarwal, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Rajni Agarwal, MD has studied deeply?
Yes, Rajni Agarwal, MD has studied treatments such as Depleted Stem Cell Transplant, JSP191, RP-L102.
What is the best way to schedule an appointment with Rajni Agarwal, MD?
Apply for one of the trials that Rajni Agarwal, MD is conducting.
What is the office address of Rajni Agarwal, MD?
The office of Rajni Agarwal, MD is located at: Lucile Packard Children's Hospital, Palo Alto, California 94305 United States. This is the address for their practice at the Lucile Packard Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.